Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis

被引:5
|
作者
Behrens, Edward M.
Beukelman, Timothy
Paessler, Michele
Cron, Randy Q.
机构
[1] Childrens Hosp, Dept Pediat, Div Rheumatol, Philadelphia, PA 19104 USA
[2] Childrens Hosp, Dept Pathol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
关键词
macrophage activation syndrome; systemic juvenile idiopathic arthritis; hemophagocytosis; CD163; antigen; bone marrow aspirate; hemophagocytic lymphohistiocytosis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Macrophage activation syndrome (MAS) is a well described, but purportedly uncommon manifestation of systemic juvenile idiopathic arthritis (SJIA). There is evidence to suggest that macrophage activation is integral to the pathogenesis of SJIA, Accordingly, many patients with SJIA may have evidence of mild MAS that is not appreciated clinically. We investigated the prevalence of occult MAS in children with SJIA by reviewing bone marrow aspirates (BMA). Methods. Patients diagnosed with SJIA who underwent bone marrow aspiration were identified retrospectively. Patients admitted with a diagnosis of fever of unknown origin and discharged with a diagnosis other than SJIA or malignancy, and who had a BMA, were identified as controls. The BMA were reviewed by a single hematopathologist for evidence of MAS, ranging from activated macrophages to frank hemophagocytic cells. Results. Eight of 15 (53%) patients with SJIA had BMA suggestive of MAS. Two of 15 patients (13%) were diagnosed clinically with MAS. Three patients (20%) were noted to have frank hemophagocytosis, only one of whom was diagnosed with MAS clinically. There were no statistically significant differences in the laboratory values for the patients with and without evidence of MAS on BMA. There was no evidence of increased macrophage activity or hemophagocytosis in any of the control BMA. Conclusion. Occult MAS appears to be common in patients with SJIA who undergo BMA. This suggests that macrophage activation may be integral to the pathogenesis of SJIA, with implications for treatment.
引用
收藏
页码:1133 / 1138
页数:6
相关论文
共 50 条
  • [21] Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis: analysis of 17 cases followed in a tertiary hospital
    Russo, Ricardo A. G.
    Katsicas, Maria M.
    Oleastro, Martias M.
    Zelazko, Marta
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2007, 105 (06): : 506 - 512
  • [22] MACROPHAGE ACTIVATION SYNDROME IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS, ONE CENTRE EXPERIENCE
    Hashad, Soad S.
    Etayari, Hala M.
    Almsellati, Iman A.
    Etfil, Majda N.
    Altwati, Aya
    Awhida, Zuhaira
    RHEUMATOLOGY, 2023, 62
  • [23] Management of Hepatitis A-induced Macrophage Activation Syndrome With Anakinra in Systemic Juvenile Idiopathic Arthritis: A Case Report
    AlNouwaiser, Deena N.
    AlMutairi, Sajdi S.
    AlRowailey, Abdullah S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [24] Macrophage Activation Syndrome Associated with Etanercept in a Child with Systemic Onset juvenile Idiopathic Arthritis
    Aikawa, Nadia Emi
    Carvalho, Jozelio Freire
    Bonfa, Eloisa
    Lotito, Ana Paola N.
    Silva, Clovis Artur A.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (10): : 635 - 636
  • [25] Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis
    Hua-Song Zeng
    Xiao-Yan Xiong
    Yan-Dan Wei
    Hong-Wei Wang
    Xiao-Ping Luo
    World Journal of Pediatrics, 2008, 4 : 97 - 101
  • [26] Macrophage Activation Syndrome in Children With Systemic Lupus Erythematosus and Children With Juvenile Idiopathic Arthritis
    Bennett, Tellen D.
    Fluchel, Mark
    Hersh, Aimee O.
    Hayward, Kristen N.
    Hersh, Adam L.
    Brogan, Thomas V.
    Srivastava, Rajendu
    Stone, Bryan L.
    Korgenski, E. Kent
    Mundorff, Michael B.
    Casper, T. Charles
    Bratton, Susan L.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (12): : 4135 - 4142
  • [27] Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era
    Ailioaie, Laura Marinela
    Ailioaie, Constantin
    Litscher, Gerhard
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [28] Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis
    Zeng, Hua-Song
    Xiong, Xiao-Yan
    Wei, Yan-Dan
    Wang, Hong-Wei
    Luo, Xiao-Ping
    WORLD JOURNAL OF PEDIATRICS, 2008, 4 (02) : 97 - 101
  • [29] Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
    Masaki Shimizu
    Mao Mizuta
    Nami Okamoto
    Takahiro Yasumi
    Naomi Iwata
    Hiroaki Umebayashi
    Yuka Okura
    Noriko Kinjo
    Tomohiro Kubota
    Yasuo Nakagishi
    Kenichi Nishimura
    Mariko Mohri
    Masato Yashiro
    Junko Yasumura
    Hiroyuki Wakiguchi
    Masaaki Mori
    Pediatric Rheumatology, 18
  • [30] Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
    Shimizu, Masaki
    Mizuta, Mao
    Okamoto, Nami
    Yasumi, Takahiro
    Iwata, Naomi
    Umebayashi, Hiroaki
    Okura, Yuka
    Kinjo, Noriko
    Kubota, Tomohiro
    Nakagishi, Yasuo
    Nishimura, Kenichi
    Mohri, Mariko
    Yashiro, Masato
    Yasumura, Junko
    Wakiguchi, Hiroyuki
    Mori, Masaaki
    PEDIATRIC RHEUMATOLOGY, 2020, 18 (01)